Immune-related adverse events in melanoma:A nationwide analysis 2016.

被引：0
|
作者：
Rai, Manoj P.
Bedi, Prabhjot Singh
Vishwanth, Rohanlal
Abu Rous, Fawzi
Shrotriya, Shiva
Dhakal, Prajwal
机构：
[1] Michigan State Univ, Sparrow Hosp, E Lansing, MI 48824 USA
[2] UPMC East, Pittsburgh, PA USA
[3] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA
[4] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e18253
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18253
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Association between immune-related adverse events and prognosis in patients treated with immune checkpoint inhibitors in melanoma: A surrogacy analysis
    Euvrard, Romain
    Robert, Marie
    Mainbourg, Sabine
    Dalle, Stephane
    Lega, Jean-Christophe
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (02) : 369 - 379
  • [32] Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study
    Pan, Catherina X.
    Kim, Daniel Y.
    Lau, Charles B.
    Lau, William C.
    Rowley, Rachael
    Kanwar, Ruhi
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (05) : 637 - 640
  • [33] Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study
    Pan, Catherina X.
    Kim, Daniel Y.
    Lau, Charles B.
    Lau, William C.
    Rowley, Rachael
    Kanwar, Ruhi
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    BRITISH JOURNAL OF DERMATOLOGY, 2023,
  • [34] IMMUNE-RELATED ADVERSE EVENTS WITH IPILIMUMAB TREATMENT OF ADVANCED MELANOMA: A SINGLE INSTITUTION EXPERIENCE
    Myrdal, C. N.
    Sundararajan, S.
    McBride, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (01) : 195 - 196
  • [35] Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma
    Woelffer, Marcus
    Battke, Florian
    Schulze, Martin
    Feldhahn, Magdalena
    Flatz, Lukas
    Martus, Peter
    Forschner, Andrea
    CANCERS, 2022, 14 (02)
  • [36] Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
    Verheijden, Rik J.
    Burgers, Femke H.
    Janssen, Josephine C.
    Putkere, Anouk E.
    Veenstra, Sophie P. G. R.
    Hospers, Geke A. P.
    Aarts, Maureen J. B.
    Hehenkamp, Karel W.
    Doorneboschj, Veerle E.
    Verhaertk, Marthe
    van den Berkmortell, Franchette W. P. J.
    Chatzidionysiou, Katerina
    Llobell, Arturo
    Barros, Milton
    Maria, Alexandre T. J.
    Takeji, Akari
    Morillo, Jose-Salvador Garcia
    Lidars, Merav
    van Eijs, Mick J. M.
    Blank, Christian U.
    Aspeslagh, Sandrine
    Piersma, Djura
    Kapiteijn, Ellen
    Labots, Mariette
    Boers-Sonderen, Marye J.
    van der Veldt, Astrid A. M.
    Haanen, John B. A. G.
    May, Anne M.
    Suijkerbuijk, Karijn P. M.
    EUROPEAN JOURNAL OF CANCER, 2024, 207
  • [37] Successful treatment with carboplatin and paclitaxel in melanoma progression after immune-related adverse events
    Dulgar, Ozgecan
    Saha, Aditi
    Elleson, Kelly M.
    Markowitz, Joseph
    IMMUNOTHERAPY, 2023, : 993 - 999
  • [38] Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations
    Park, Benjamin C. C.
    Narayanan, Sathya
    Gavraldis, Alexander
    Ye, Fei
    Fan, Run
    Sullivan, Ryan J. J.
    Boland, Genevieve
    Reynolds, Kerry L.
    Balko, Justin M. M.
    Carlino, Matteo S. S.
    Long, Georgina V. V.
    Zubiri, Leyre
    Menzies, Alexander M. M.
    Johnson, Douglas B. B.
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [39] Intracranial Tumor Control After Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma
    Zhang, Michael
    Rodrigues, Adrian J.
    Bhambhvani, Hriday P.
    Fatemi, Parastou
    Pollom, Erqi L.
    Gibbs, Iris C.
    Thomas, Reena P.
    Soltys, Scott G.
    Hancock, Steven L.
    Chang, Steven D.
    Reddy, Sunil A.
    Gephart, Melanie Hayden
    Li, Gordon
    WORLD NEUROSURGERY, 2020, 144 : E316 - E325
  • [40] Delayed immune-related adverse events with an PD-1-based immunotherapy in melanoma
    Owen, C. N.
    Bai, X.
    Quah, T.
    Lo, S. N.
    Allayous, C.
    Callaghan, S.
    Martinez-Vila, C.
    Wallace, R.
    Bhave, P.
    Reijers, I. L. M.
    Thompson, N.
    Vanella, V.
    Gerard, C. L.
    Aspeslagh, S.
    Labianca, A.
    Khattak, A.
    Mandala, M.
    Xu, W.
    Neyns, B.
    Michielin, O.
    Blank, C. U.
    Welsh, S. J.
    Haydon, A.
    Sandhu, S.
    Mangana, J.
    McQuade, J. L.
    Ascierto, P. A.
    Zimmer, L.
    Johnson, D. B.
    Arance, A.
    Lorigan, P.
    Lebbe, C.
    Carlino, M. S.
    Sullivan, R. J.
    Long, G., V
    Menzies, A. M.
    ANNALS OF ONCOLOGY, 2021, 32 (07) : 917 - 925
12345